YU36900A - Intraoralni i intranazalni transmukozni preparat koji sadrži levosimendan - Google Patents
Intraoralni i intranazalni transmukozni preparat koji sadrži levosimendanInfo
- Publication number
- YU36900A YU36900A YU36900A YU36900A YU36900A YU 36900 A YU36900 A YU 36900A YU 36900 A YU36900 A YU 36900A YU 36900 A YU36900 A YU 36900A YU 36900 A YU36900 A YU 36900A
- Authority
- YU
- Yugoslavia
- Prior art keywords
- levosimendan
- transmucosal
- preparation
- treatment
- source
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/50—Pyridazines; Hydrogenated pyridazines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0043—Nose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
Landscapes
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Urology & Nephrology (AREA)
- Reproductive Health (AREA)
- Gynecology & Obstetrics (AREA)
- Cardiology (AREA)
- Otolaryngology (AREA)
- Dermatology (AREA)
- Physiology (AREA)
- Nutrition Science (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Heart & Thoracic Surgery (AREA)
- Hospice & Palliative Care (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Luminescent Compositions (AREA)
- Paper (AREA)
- Air Bags (AREA)
Abstract
Opisan je intraoralni ili intranazalni transmukozni preparat koji sadrži levosimendan ili njegovu farmaceutski prihvatljivu so kao aktivnu komponentu. Ovaj preparat je bukalni, sublingualni ili sinuidalni transmukozni preparat. Opisana je upotreba ovog preparata za proizvodnju medikamenta - leka za transmukoznu primenu oralne ili nazalne mukoze za tretiranje srčanog udara.[Described is a method of administering transmucosally, particularly to oral or nasal mucosa, levosimendan or a pharmaceutically acceptable salt thereof to a patient. The method comprises contacting an intact mucous membrane with a source of levosimendan, and maintaining said source in contact with said mucous membrane for a sufficient time period to deliver levosimendan to the patient. Transmucosal preparations of levosimendan are also described. Levosimendan is useful in the treatment of heart failure.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FI974578A FI974578L (fi) | 1997-12-19 | 1997-12-19 | Menetelmä levosimendaanin antamiseksi |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| YU36900A true YU36900A (sh) | 2003-02-28 |
| RS49889B RS49889B (sr) | 2008-08-07 |
Family
ID=8550178
Country Status (26)
| Country | Link |
|---|---|
| US (1) | US6399610B1 (sh) |
| EP (1) | EP1052973B1 (sh) |
| JP (1) | JP2001526205A (sh) |
| KR (1) | KR100753689B1 (sh) |
| AT (1) | ATE215358T1 (sh) |
| AU (1) | AU738082B2 (sh) |
| BR (1) | BR9813641A (sh) |
| CA (1) | CA2313618C (sh) |
| CZ (1) | CZ296693B6 (sh) |
| DE (1) | DE69804678T2 (sh) |
| DK (1) | DK1052973T3 (sh) |
| EA (1) | EA002197B1 (sh) |
| EE (1) | EE04330B1 (sh) |
| ES (1) | ES2175827T3 (sh) |
| FI (1) | FI974578L (sh) |
| HR (1) | HRP20000400B1 (sh) |
| HU (1) | HU226736B1 (sh) |
| IL (1) | IL136415A (sh) |
| NO (1) | NO320050B1 (sh) |
| NZ (1) | NZ504806A (sh) |
| PL (1) | PL191868B1 (sh) |
| PT (1) | PT1052973E (sh) |
| RS (1) | RS49889B (sh) |
| SK (1) | SK284838B6 (sh) |
| WO (1) | WO1999032081A1 (sh) |
| ZA (1) | ZA9811405B (sh) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FI980901A7 (fi) * | 1998-04-23 | 1999-10-24 | Orion Yhtymae Oyj | Levosimendaania säädellysti vapauttavia oraalisia koostumuksia |
| FI20002755A0 (fi) | 2000-12-15 | 2000-12-15 | Orion Yhtymae Oyj | Menetelmä erektiilin dysfunktion hoitamiseen |
| CN100428937C (zh) * | 2003-10-30 | 2008-10-29 | 北京海合天科技开发有限公司 | 左西孟旦冷冻干燥组合物 |
| FI20040674A0 (fi) | 2004-05-12 | 2004-05-12 | Orion Corp | Menetelmä tromboembolisten sairauksien estoon |
| WO2006089082A2 (en) * | 2005-02-17 | 2006-08-24 | Velcera Pharmaceuticals | Transmucosal administration of drug compositions for treating and preventing disorders in animals |
| US20070032557A1 (en) * | 2005-02-18 | 2007-02-08 | Matti Kivikko | Method for administering levosimendan |
| WO2007096906A2 (en) * | 2006-02-27 | 2007-08-30 | Panacea Biotec Ltd. | Novel buccoadhesive compositions and process of preparation thereof |
| JP2010504931A (ja) * | 2006-09-27 | 2010-02-18 | ニコノヴァム エービー | 指向性の使用 |
| US11523986B2 (en) * | 2019-03-22 | 2022-12-13 | Dbbh, Llc | Intranasally administered antihistamines and uses thereof |
| WO2021001601A1 (en) * | 2019-07-01 | 2021-01-07 | Orion Corporation | Methods for administering (r)-n-[4-(1,4,5,6-tetrahydro-6-oxo-3-pyridazinyl)phenyl]acetamide |
| US11969424B2 (en) | 2019-12-16 | 2024-04-30 | Tenax Therapeutics, Inc. | Levosimendan for treating pulmonary hypertension with heart failure with preserved ejection fraction (PH-HFpEF) |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB2251615B (en) | 1991-01-03 | 1995-02-08 | Orion Yhtymae Oy | (-)-[[4-(1,4,5,6-tetrahydro-4-methyl-6-oxo-3-pyridazinyl)phenyl]hydrazono]pro panedinitrile |
| GB2266841A (en) * | 1992-05-06 | 1993-11-17 | Orion Yhtymae Oy | Compounds for use as anti-ischemic medicaments |
| US5688520A (en) * | 1995-03-29 | 1997-11-18 | Minnesota Mining And Manufacturing Company | Transmucosal delivery of melatonin for prevention of migraine |
| GB9614098D0 (en) * | 1996-07-05 | 1996-09-04 | Orion Yhtymae Oy | Transdermal delivery of levosimendan |
-
1997
- 1997-12-19 FI FI974578A patent/FI974578L/fi unknown
-
1998
- 1998-12-11 HU HU0100452A patent/HU226736B1/hu not_active IP Right Cessation
- 1998-12-11 PL PL341202A patent/PL191868B1/pl not_active IP Right Cessation
- 1998-12-11 DE DE69804678T patent/DE69804678T2/de not_active Expired - Lifetime
- 1998-12-11 BR BR9813641-0A patent/BR9813641A/pt not_active Application Discontinuation
- 1998-12-11 AU AU15656/99A patent/AU738082B2/en not_active Ceased
- 1998-12-11 ES ES98959930T patent/ES2175827T3/es not_active Expired - Lifetime
- 1998-12-11 EP EP98959930A patent/EP1052973B1/en not_active Expired - Lifetime
- 1998-12-11 DK DK98959930T patent/DK1052973T3/da active
- 1998-12-11 EE EEP200000368A patent/EE04330B1/xx not_active IP Right Cessation
- 1998-12-11 ZA ZA9811405A patent/ZA9811405B/xx unknown
- 1998-12-11 PT PT98959930T patent/PT1052973E/pt unknown
- 1998-12-11 EA EA200000686A patent/EA002197B1/ru not_active IP Right Cessation
- 1998-12-11 CA CA002313618A patent/CA2313618C/en not_active Expired - Fee Related
- 1998-12-11 CZ CZ20002155A patent/CZ296693B6/cs not_active IP Right Cessation
- 1998-12-11 WO PCT/FI1998/000977 patent/WO1999032081A1/en not_active Ceased
- 1998-12-11 NZ NZ504806A patent/NZ504806A/en unknown
- 1998-12-11 AT AT98959930T patent/ATE215358T1/de not_active IP Right Cessation
- 1998-12-11 RS YUP-369/00A patent/RS49889B/sr unknown
- 1998-12-11 JP JP2000525076A patent/JP2001526205A/ja active Pending
- 1998-12-11 SK SK906-2000A patent/SK284838B6/sk not_active IP Right Cessation
- 1998-12-11 IL IL13641598A patent/IL136415A/xx not_active IP Right Cessation
- 1998-12-11 KR KR1020007006835A patent/KR100753689B1/ko not_active Expired - Fee Related
- 1998-12-11 US US09/581,610 patent/US6399610B1/en not_active Expired - Fee Related
- 1998-12-11 HR HR20000400A patent/HRP20000400B1/xx not_active IP Right Cessation
-
2000
- 2000-06-14 NO NO20003059A patent/NO320050B1/no not_active IP Right Cessation
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE468845T2 (de) | Bukkale transmukosale arzneidarreichung unter verwendung einer festen lösung | |
| DE69916486D1 (de) | Nicotin enthaltende pharmazeutische zusammensetzungen mit schneller transmukosaler absorption | |
| KR970703151A (ko) | 알렌드로네이트의 경구 액상 제형(Oral liquid alendronate formulations) | |
| DK1471890T3 (da) | Farmaceutisk doseringsform til mukös afgivelse | |
| CA2569674A1 (en) | Sublingual buccal effervescent | |
| MY127422A (en) | Low dose entecavir formulation and use | |
| JP5897509B2 (ja) | 口内で使用される窪みのある接着性口内パッチ | |
| YU36900A (sh) | Intraoralni i intranazalni transmukozni preparat koji sadrži levosimendan | |
| MX2010010839A (es) | Composicion para la higiene oral y aparato y metodo. | |
| RU2001126555A (ru) | Составы фармацевтической жевательной резинки | |
| JP2008542299A5 (sh) | ||
| WO2000056344A1 (fr) | Salive artificielle | |
| RU92011840A (ru) | Состав для профилактики заболеваний пародонта и слизистой оболочки полости рта "биостом" | |
| WO2008111384A1 (ja) | 上皮改善剤 | |
| EP0315332B1 (en) | Antitussive liquid compositions containing phenol | |
| JP2005518435A5 (sh) | ||
| UA37278C2 (uk) | Протикашльова фармацевтична композиція для перорального введення | |
| WO2001074396A8 (en) | Composition and method for promoting oral health | |
| Bhowmik et al. | Buccal drug delivery system-a novel drug delivery system | |
| Yun et al. | Pharmaceutical devices for oral cavity-based local and systemic drug delivery | |
| DK1448184T3 (da) | Anvendelse af propionyl-L-carnitin eller et af dets farmakologisk acceptable salte til fremstilling af en medicin til behandling af Peyronies sygdom | |
| Chauhan et al. | Cultural Practices involving Teeth and Oro-facial Soft Tissues–A Review | |
| MD1469G2 (ro) | Metodă de tratament al şocului combustional | |
| KR20060115092A (ko) | 니코틴을 함유하는 구강청정제 |